Rapid Micro - רווח נקי למניה ב-12 החודשים האחרונים RPID

Rapid Micro Biosystems (RPID) business development relies on the implementation of Growth Direct systems in pharmacology and the sale of test cassettes, although sanctions and geopolitical fragmentation limit the export of high-precision instruments. This price chart reflects EPS (TTM) dynamics at -11.70. Stable cash flow is ensured by long-term service contracts and the relevance of the equipment, which serve as a reliable financial foundation for the company.

Earnings per share dynamics determine the balance between operational risks and return on equity. Comparing year-over-year EPS (TTM) visualizes the rate of change in net income over twelve months relative to the same period last year. This indicator measures cost management efficiency and the business's ability to scale profits. For Rapid Micro Biosystems (RPID), this reflects the impact of R&D scientist costs against a backdrop of high production automation.